results to children and adult relatives were led only by their providers (38.2%-39.2%), as opposed to being led by the patient, both parties, or neither party. Providers were most likely to lead these discussions when mothers had stronger family histories of cancer and expressed more confidence about making a decision to talk to their children about BRCA. However, mothers typically led such discussions if they were raising older children and held more positive attitudes about pediatric BRCA testing.
BRCA PV have a 50% chance of inheriting the alteration, and adult relatives are at risk of being carriers. However, cancer risks and recommendations for medical management generally do not apply until adulthood. 3, 7 Thus, genetic testing in minor children is discouraged. 8, 9 Our prior research demonstrates that among mothers undergoing BRCA testing, the majority will disclose results indicating either the presence or absence of a PV to their children, including minors. [10] [11] [12] Indeed, much of the motivation for mothers seeking testing relates to their beliefs that the information is relevant and beneficial for their children, including the prospect of pediatric BRCA testing. [12] [13] [14] [15] [16] However, mothers commonly report unmet education and support needs when making decisions about sharing information about inherited HBOC risk results with children and other relatives. [17] [18] [19] These unmet needs raise important questions about the extent to which these issues are being addressed as part of the process of BRCA genetic counseling and testing.
Post-test genetic counseling sessions (ie, when patients obtain their BRCA results from their provider and discuss the associated 2 | METHODS
| Study design and participants
Data were drawn from the 1-month follow-up survey of a trial of BRCA genetic counseling outcomes. Participants (N = 211) were female patients who self-reported as being mothers to at least 1 child age 8 to 17 years. This group represented 75% of the 283 patients approached for inclusion in the trial and 97% of those who consented to the research (n = 217).
| Study procedures
Complete details are provided elsewhere. 20 Briefly, participants at 2 
| Clinical variables
Data regarding participants' proband status (ie, the first family member to seek BRCA genetic counseling/testing), personal history of breast or ovarian cancer, and family history of breast or ovarian cancer (among first-and second-degree relatives) were collected and verified by genetic counseling providers and medical record review. Participants'
BRCA test results were also documented as a descriptive variable.
| Knowledge
Knowledge about BRCA testing and risks/benefits of communication with children was assessed using a trial-specific 16-item true/false scale (Cronbach's α = 0.91).
| Distress
Psychological distress was assessed with the anxiety and depression subscales of the 12-item Brief Symptom Inventory. 22 Scores range from 12 to 48 with higher scores indicating greater distress (α = 0.89). 
| Parent-child communication

| Pediatric genetic testing attitudes
The 11-item Pediatric BRCA Testing Attitudes Scale was used to assess participants' attitudes toward testing minor children for HBOC genes. 13 The Pediatric BRCA Testing Attitudes Scale is a valid selfreport measure of parents' own beliefs about risks and benefits of BRCA testing in childhood, decision-making, and communication of genetic testing results to children. Scores range from 11 to 55; higher scores indicate more positive attitudes (α = 0.91).
| Decision self-efficacy
A modified version of the 11-item Decision Self-Efficacy Scale 24 was used to measure participants' self-confidence in their ability to make an informed choice about discussing their BRCA results with their children. Scores range from 0 to 44, with higher scores indicating greater confidence in one's decision-making capacity (α = 0.87). 
2.4
| Statistical analyses
Descriptive statistics were computed to characterize the study sample.
Next, chi-squared tests were used to examine bivariate associations between conceptually corresponding pairs of GCCP items (eg, items describing whether the provider or patient raised an issue during the session). Then, the reliability and validity of the GCCP measure were examined through a combination of exploratory factor analysis and confirmatory factor analysis using Mplus 7.4. Finally, bivariate analyses (ie, t-tests, Pearson's r correlations) and multivariable linear regressions were used to examine associations between participant sociodemographic, clinical, and psychosocial factors and aspects of the genetic counseling session measured by the GCCP. All statistical tests were 2-tailed with α = 0.05.
3 | RESULTS
| Participant characteristics
Participant characteristics (N = 211) are shown in Table 1 . Mothers were mostly non-Hispanic white (73.0%), had a college education (78.2%), and were married or living as married (79.1%). The majority (86.3%) were the proband, and approximately half (54.0%) had been diagnosed with breast or ovarian cancer (ie, were cancer survivors).
Through genetic counseling and testing, 9% of participants received a positive (ie, PV) BRCA result.
| GCCP item-level analysis
We compared the distribution of responses for conceptually corre- In comparing the distribution of items regarding seeking information, support, and education, 14.4% of patients reported that they asked for these resources for both their adult relatives and minor-age children, 2.9% asked for these resources for only their adult relatives, 9.6% asked for only their children, and 73.1% of patients reported that they did not ask for these resources for either their adult relatives or children (χ 2 = 83.82 (1 df), P < 0.0001). Although infrequently requested, these resources were more likely to be requested for children than adult relatives. Furthermore, 46.4% of patients reported that information about whether or how to communicate with both adult relatives and minorage children was discussed during the session, whereas 8.2% of patients reported that only communication with adult relatives was discussed, 9.7% reported that only communication with minor-aged children was discussed, and 35.8% reported that communication with neither was discussed (χ 2 = 84.46 (1 df), P < 0.0001). These results suggest that information about whether or how to communicate was discussed more frequently for children than for adult relatives.
| Reliability and validity
To examine the reliability and validity of the GCCP measure, we first As These findings support the 2 factors identified in the GCCP scale:
findings for this solution in the complete sample are shown in Table 2 . 
| Bivariate analysis
Bivariate correlations among the GCCP outcome variables and patient sociodemographic, clinical, and psychosocial factors are shown in Table 3 . Greater patient-led communication scores were significantly associated with the patient having an older child (r = 0.20, P = 0.003) and holding more positive attitudes toward pediatric BRCA testing (r = 0.15, P = 0.03). Patient-led discussions were not associated with either proband (P = 0.13) or survivorship statuses (P = 0.35).
Greater provider-led communications were significantly associated with mothers having more extensive cancer family histories (number of affected second-degree relatives: r = 0.18, P = 0.01; number of affected first-degree and second-degree relatives: r = 0.19, 
| Multivariable analyses
Variables significantly associated (P < 0.05) with GCCP outcomes in bivariate analyses were examined in separate multivariable linear regression models (Table 4) Both "family history (second degree)" and "family history (first and second degree)" were significantly associated with provider-led communication in bivariate analyses; however, the latter provides a more comprehensive assessment of family history and was therefore included in the multivariable analysis. have been intended to be addressed at a later time by the provider) or because providers did not attend to these issues. It is also possible that mothers initiated these discussions preemptively out of high concern for the well-being of their children and adult relatives. Providers may have initiated conversations about family communication primarily when they felt that it was most relevant, or when they perceived that mothers were most able to assimilate the information. In either instance, it is important to assess the outcomes of counseling and examine its process and content to advance our understanding of care delivery and ensure that patients' needs are met.
| Limitations
The patient sample was not highly diverse (ie, few racial/ethnic minority participants, high socioeconomic status overall). Notably, most participants were from high-risk HBOC kindreds, and very few (9%) received PV BRCA results, thereby attenuating our ability to detect meaningful differences in outcome by maternal test result. Thus, it will be critical for future, larger studies to determine whether these findings generalize to other testing contexts and clinical populations. The GCCP measure was obtained 1 month after genetic counseling. Content of the genetic counseling sessions was not standardized, and variability may have existed across counseling sessions consistent with real-world variability that can occur in practice. Although family communication is more likely to be discussed in-depth during post-test counseling sessions, it is possible that some issues were raised prior to counseling or subsequently.
Furthermore, because these data were cross-sectional, we cannot determine whether associations between psychosocial factors (eg, decision self-efficacy) and communication outcomes were bidirectional or operate in the opposite direction. Finally, it is possible that participants' recollections of their genetic counseling sessions were suboptimal; direct observation methods along with longitudinal study designs could help verify patient reports and provide more nuanced information about the process and content of these interactions.
| Clinical implications
Future research could assess concordance between patient-provider perceptions of discussions about family disclosure of test results and BRCA implications for relatives. Discrepancies in concordance as well as topics that tend to be raised more by patients than providers would suggest that cancer genetic counseling sessions adopt a more consistent approach to discussing such issues with patients. Future research should also examine how patient-led or provider-led discussions about family disclosure ultimately influence patients' familial dissemination of their BRCA genetic testing experiences and results.
Currently, many probands who undergo HBOC genetic testing are offered the option of multi-gene panel testing rather than BRCA testing alone. [27] [28] [29] Implications of panel test results for family members can be far more complex owing to uncertainty in cancer risks of PV in other genes, the potential for learning about elevated risks for cancers that are inconsistent with one's personal and/or family history, and the likelihood that more variants of uncertain significance will be identified. [30] [31] [32] Finally, alternative service delivery models are increasingly being used to meet demands for HBOC genetic counseling (eg, telephone, video, or group counseling). 33 Assessing patientprovider communication in these settings compared with traditional in-person counseling may elucidate whether patterns of communication are different and whether that may impact patient satisfaction and outcomes. Those data could inform the development of genetic counseling protocols. Overall, it will be important that patients and providers understand and attend to the familial implications of increasingly complex results, and for researchers to assess how to optimize patient education and satisfaction with the discussion of these concerns during genetic counseling.
In conclusion, it is important to assess whether and how discussions about family communication and genetic testing implications, both for adult and child relatives, occur during the process of genetic counseling. 
